The tariff classification of Doxorubicin Hydrochloride Liposome Injection in dosage form, from Italy
Reasoning
The tariff classification of Doxorubicin Hydrochloride Liposome Injection in dosage form, from Italy
Cite this ruling
CBP Ruling N357819 (3004200075): The tariff classification of Doxorubicin Hydrochloride Liposome Injection in dosage form, from Italy
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300420
The tariff classification of Tobramycin Injection in dosage form, from China
The tariff classification of Clindamycin Palmitate Oral Solution in dosage form, from India
The tariff classification of Vancomycin Hydrochloride Injection in dosage form, from China
The tariff classification of Daptomycin Injection in dosage form, from China
The tariff classification of Minocycline Hydrochloride Extended-Release Tablets in dosage form, from Italy